AION Labs CEO, Mati Gill, discusses the company’s extensive backing from pharma and tech giants to build AI startups, and how AION is looking beyond AI to explore quantum technologies for research and development in drug discovery. Global AI By HIMSS TV | January 23, 2026 | 9:46 AM Tags: clinical AI, drug discovery